Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

Apr 16, 2024 05:00 ET
GPTBots.AI Unveils Asia’s First “On-premise AI Bot Platform”
GPTBots.AI, the AI bot creation platform of Aurora Mobile Limited (NASDAQ: JG), introduces a groundbreaking AI Bot Development Platform, empowering businesses to effortlessly custom-build and train their own exclusive AI bots. Distinguished as...
Apr 16, 2024 05:00 ET
LoRa Alliance® Unveils LoRaWAN® Development Roadmap; The Standard’s Success Guides Its Future Evolution and Direction
The LoRa Alliance®, the global association of companies backing the open LoRaWAN® standard for the internet of things (IoT) low-power wide-area networks (LPWANs), today launched its formal roadmap, which highlights LoRaWAN’s evolution from building...
Apr 16, 2024 04:35 ET
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
Human Pharma sales up 10.3%* to EUR 20.8 bn, driven by JARDIANCE® and OFEV®Animal Health sales up 6.9 %* to EUR 4.7 bn, fueled by new product launchesR&D expenditures increase by 14.2% to EUR 5.8 bn Boehringer Ingelheim today...
Apr 16, 2024 04:00 ET
Counslr Expands into Michigan, Partnering with Dearborn Heights District 7 to Increase Mental Health Support Services
Counslr, the text-based mental health support mobile app, announced today that it has expanded its support in the State of Michigan through a partnership with the Dearborn Heights District 7 School District. Both students and faculty will now have...
Apr 16, 2024 04:00 ET
DKS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Dick's Sporting Goods, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Dick's Sporting Goods, Inc. (“Dick's Sporting Goods” or “the Company”) (NYSE: DKS)...
Apr 16, 2024 04:00 ET
LUNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Luna Innovations Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Luna Innovations Incorporated (“Luna Innovations” or “the Company”) (NASDAQ: LUNA)...
Apr 16, 2024 04:00 ET
RNWK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that RealNetworks, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against RealNetworks, Inc. (“RealNetworks” or “the Company”) (NASDAQ: RNWK) and certain of...
Apr 16, 2024 04:00 ET
SNOW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Snowflake Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Snowflake Inc. (“Snowflake” or “the Company”) (NYSE: SNOW) and certain of its...
Apr 16, 2024 04:00 ET
VTYX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ventyx Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Ventyx Biosciences, Inc. (“Ventyx” or “the Company”) (NASDAQ: VTYX) and certain of...
Apr 16, 2024 03:05 ET
LIFT intersects 24 m at 1.33% Li2O at its Echo pegmatite, Yellowknife Lithium Project, NWT
Li-FT Power Ltd. (“LIFT” or the “Company”) (TSXV: LIFT) (OTCQX: LIFFF) (Frankfurt: WS0) is pleased to report assays from 17 drill holes completed at the Echo, Fi Main, & Fi Southwest pegmatites within the Yellowknife Lithium Project (“YLP”) located...
Apr 16, 2024 03:01 ET
CancerVax Announces Promising New Drug to Treat a Deadly Children’s Cancer
Santa Barbara, CA, April 16, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of breakthrough cancer drugs that will use the body’s immune system to fight cancer, today announced that its UCLA research team has created a promising new drug...
Apr 16, 2024 03:01 ET
GLP Selects Zscaler to Accelerate its Cloud Security Transformation Journey
Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, announced that GLP, a global real estate logistics provider and investment manager, is leveraging Zscaler for Users, part of the AI-powered Zscaler Zero Trust Exchange™ cloud security...
Apr 16, 2024 02:30 ET
Nxera Pharma Notes Successful Development Progress of Partnered Schizophrenia Candidate NBI-1117568
NBI-1117568 is an oral, selective muscarinic M4 receptor agonist advancing through Phase 2 clinical development under a multi-program collaboration with Neurocrine BiosciencesSuccessful completion of a long-term preclinical toxicity program to...
Apr 16, 2024 02:00 ET
Caledonia Mining Corporation Plc: Notification of relevant change to significant shareholder
Caledonia Mining Corporation Plc ("Caledonia" or "the Company") (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) announces that it received notification on April 15, 2024 from BlackRock, Inc. that on April 12, 2024 it had crossed a threshold for...
Apr 16, 2024 02:00 ET
Cornish Metals Corporate Update - South Crofty Tin Project
Cornish Metals Inc. (AIM/TSX-V: CUSN) (“Cornish Metals” or the “Company”) is pleased to provide an update on current activities at its 100% owned South Crofty tin project located in Cornwall, United Kingdom. Highlights The South Crofty...
Apr 16, 2024 02:00 ET
Faron Confirms Plans for the Coming Months Under New Leadership
Faron Pharmaceuticals Ltd. (“Faron” or the “Company”) (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company pursuing a CLEVER approach to reprogramming myeloid cells to activate anti-tumor immunity in hematological and solid...
Apr 16, 2024 02:00 ET
Microex Launches Web3.0 Financial Trading Solution - Pioneering Innovation in Financial Technology
Microex, a UAE-based financial technology company, today announced the launch of its web3.0 financial trading solution. This innovative platform marks a significant step forward in the financial technology industry. Since its founding in August...
Apr 16, 2024 01:30 ET
Vallourec announces an offering of $820 million of 8-year Senior Notes
Vallourec announces an offering of $820 million of 8-year Senior Notes Meudon (France), April 16, 2024 – Vallourec, a world leader in premium tubular solutions, announces today the launch of an offering of its Senior Notes due 2032 (the “Notes”) in...
Apr 16, 2024 01:00 ET
argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease
ADHERE data show VYVGART® Hytrulo has potential to be first advancement for CIDP patients in 30 years Real-world data demonstrate gMG patients able to significantly reduce steroid use over first six months of initiating VYVGART® treatment April...
Apr 16, 2024 00:28 ET
Ultra Lithium Provides Bi-Weekly Default Status Report
Ultra Lithium Inc. (TSXV: ULT OTCQB: ULTXF Frankfurt: QFB) (“Ultra Lithium” or the “Company”) is providing this bi-weekly default status report in accordance with National Policy 12-203 Management Cease Trade Orders (“NP 12-203”). On March 4, 2024,...